Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY3023703 in postsurgical dental pain
NCT01872910Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY3023703 in acute pain, sponsored by Eli Lilly and Company. Started Jun 2013; status: completed.
02
Drugs
LY3023703
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01872910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01872910.